ArticleOncotarget2017

Efficacy and safety of everolimus in Chinese metastatic HR positive, HER2 negative breast cancer patients: a real-world retrospective study.

Chengcheng Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.